Á¦6ȸ °¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿ø ¾Ï ½ÉÆ÷Áö¾ö(¿ÀÇÁ¶óÀÎ/¿Â¶óÀÎ) : 2024-07-26
±³À°ÀÏÀÚ : 2024-07-26
±³À°Àå¼Ò : ¾Ïº´¿ø 10Ãþ ¼º¹Ù¿À·ÎȦ ¿Ü 2°³·ë / ¿Â¶óÀÎ Çмú´ëȸ(ZOOM)
±³À°ÁÖÁ¦ : Á¦6ȸ °¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿ø ¾Ï ½ÉÆ÷Áö¾ö(¿ÀÇÁ¶óÀÎ/¿Â¶óÀÎ)
ÁÖÃÖ±â°ü : °¡Å縯´ëÇб³¼ººó¼¾Æ®º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼ººó¼¾Æ®º´¿ø
´ã´çÀÚ : ¹é½Â
¿¬¶ôó : 031-249-8020
À̸ÞÀÏ : skydad100@naver.com
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, Á¤½Å°Ç°ÀÇÇаú, Á¤Çü¿Ü°ú, ¾È°ú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ÀçÈ°ÀÇÇаú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀÎ : 300¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 7 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 10,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ ¼º¹Ù¿À·ÎȦ 12:40~13:00 Mastering Stress and Sleep Management in Cancer Care ±è¿µÂù(¼ººó¼¾Æ®º´¿ø Á¤½Å°Ç°ÀÇÇаú)
±³À°½Ã°£ 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ ¼º¹Ù¿À·ÎȦ 13:00~13:20 Optimizing Nutrition Support for Enhanced Cancer Care ¹Ú±â¹ü(¼ººó¼¾Æ®º´¿ø ¿Ü°ú)
±³À°½Ã°£ 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ ¼º¹Ù¿À·ÎȦ 13:20~13:40 Comprehensive Nursing Care for Cancer Patients Á¤¼±¿µ(¼ººó¼¾Æ®º´¿ø °£È£ºÎ)
Åä·Ð 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ ¼º¹Ù¿À·ÎȦ 13:40~13:50 ÁúÀÇ ¹× ´äº¯ ()
±³À°½Ã°£ 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ ¼º¹Ù¿À·ÎȦ 13:50~14:20 Digital Pathology : Advancing Cancer Diagnosis with Technology ÀÌÀ¯Áø(¼ººó¼¾Æ®º´¿ø º´¸®°ú)
±³À°½Ã°£ 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ ¼º¹Ù¿À·ÎȦ 14:20~14:50 Artificial Intelligence in Oncological imaging Á¤¹Î°æ(¼ººó¼¾Æ®º´¿ø ¿µ»óÀÇÇаú)
±³À°½Ã°£ 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ ¼º¹Ù¿À·ÎȦ 14:50~15:20 NAVIFY : Enhancing Cancer Care with Smart Date Solutions ½ÅÁöÀº(¼ººó¼¾Æ®º´¿ø Á¾¾ç³»°ú)
±³À°½Ã°£ 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ 1,2 ¼¼¹Ì³ª½Ç 13:50~14:20 AI-EKG¸¦ È°¿ëÇÑ ½ÉÀåÁúȯ Áø´Ü ȲÀ¯¹Ì(¼ººó¼¾Æ®º´¿ø ¼øȯ±â³»°ú)
±³À°½Ã°£ 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ 1,2 ¼¼¹Ì³ª½Ç 14:20~14:50 ½º¸¶Æ® ÅëÁõ ¸ð´ÏÅ͸µ : ¼ö¼ú ÈÄ È¯ÀÚ °ü¸®ÀÇ »õ·Î¿î Æз¯´ÙÀÓ ¹ÚµµÁØ(¼ººó¼¾Æ®º´¿ø Á¤Çü³»°ú)
±³À°½Ã°£ 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ 1,2 ¼¼¹Ì³ª½Ç 14:50~15:20 ȯÀÚ¾ÈÀüÀ» À§ÇÑ AI È°¿ë ¹× CDSS °³¹ß Á¤¿¬¿õ(¼ººó¼¾Æ®º´¿ø ¾È°ú)
Åä·Ð 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ ¼º¹Ù¿À·ÎȦ 15:20~15:30 ÁúÀÇ ¹× ´äº¯ ()
ÈÞ½Ä 07¿ù 26ÀÏ 15:20~15:30 ÈÞ½Ä ()
±³À°½Ã°£ 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ ¼º¹Ù¿À·ÎȦ 15:30~16:00 What is the potential application of PSMA PET/CT in prostate cancer À±ÇõÁø(¼ººó¼¾Æ®º´¿ø ÇÙÀÇÇаú)
±³À°½Ã°£ 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ ¼º¹Ù¿À·ÎȦ 16:00~16:30 PSMA - Targeting Treatments for Mcrpc ±èÇöÈ£(¼ººó¼¾Æ®º´¿ø Á¾¾ç³»°ú)
±³À°½Ã°£ 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ ¼º¹Ù¿À·ÎȦ 16:30~17:00 Optimal treatment for high risk prostate cancer in the PSMA era ÃÖ¿µÈ¿(¼ººó¼¾Æ®º´¿ø ºñ´¢ÀÇÇаú)
±³À°½Ã°£ 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ 1,2 ¼¼¹Ì³ª½Ç 15:30~16:00 ½º¸¶Æ®±â±â¸¦ È°¿ëÇÑ ³ë¼è/±Ù°¨¼ÒÁõ Áø´Ü ±èÇϳª(¼ººó¼¾Æ®º´¿ø °¡Á¤ÀÇÇаú)
±³À°½Ã°£ 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ 1,2 ¼¼¹Ì³ª½Ç 16:00~16:30 Æó¾Ï ȯÀÚ¿¡¼ ¼ö¼ú ÈÄ ½º¸¶Æ®±â±â¸¦ È°¿ëÇÑ È£ÈíÀçÈ° À±¹ÌÁ¤(¼ººó¼¾Æ®º´¿ø ÀçÈ°ÀÇÇаú)
±³À°½Ã°£ 07¿ù 26ÀÏ ¾Ïº´¿ø10Ãþ 1,2 ¼¼¹Ì³ª½Ç 16:30~17:00 ¾È¸éÀνÄÀ» È°¿ëÇÑ °Ç°»óÅÂÈ®ÀÎ ¾Ë°í¸®Áò °³¹ß À±Àç½Â(¼ººó¼¾Æ®º´¿ø ³»ºÐºñ³»°ú)